Lu M - Search Results

1

Detailed mechanistic insights into HIV-1 sensitivity to three generations of fusion inhibitors.

Eggink D, Langedijk JP, Bonvin AM, Deng Y, Lu M, Berkhout B, Sanders RW. Eggink D, et al. Among authors: lu m. J Biol Chem. 2009 Sep 25;284(39):26941-50. doi: 10.1074/jbc.M109.004416. Epub 2009 Jul 17. J Biol Chem. 2009. PMID: 19617355 Free PMC article.

2

Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor.

Baldwin CE, Sanders RW, Deng Y, Jurriaans S, Lange JM, Lu M, Berkhout B. Baldwin CE, et al. Among authors: lu m. J Virol. 2004 Nov;78(22):12428-37. doi: 10.1128/JVI.78.22.12428-12437.2004. J Virol. 2004. PMID: 15507629 Free PMC article.

3

Selection of T1249-resistant human immunodeficiency virus type 1 variants.

Eggink D, Baldwin CE, Deng Y, Langedijk JP, Lu M, Sanders RW, Berkhout B. Eggink D, et al. Among authors: lu m. J Virol. 2008 Jul;82(13):6678-88. doi: 10.1128/JVI.00352-08. Epub 2008 Apr 23. J Virol. 2008. PMID: 18434391 Free PMC article.

4

Evolutionary repair of HIV type 1 gp41 with a kink in the N-terminal helix leads to restoration of the six-helix bundle structure.

Sanders RW, Busser E, Moore JP, Lu M, Berkhout B. Sanders RW, et al. Among authors: lu m. AIDS Res Hum Retroviruses. 2004 Jul;20(7):742-9. doi: 10.1089/0889222041524544. AIDS Res Hum Retroviruses. 2004. PMID: 15307920

5

Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Sanders RW, Vesanen M, Schuelke N, Master A, Schiffner L, Kalyanaraman R, Paluch M, Berkhout B, Maddon PJ, Olson WC, Lu M, Moore JP. Sanders RW, et al. Among authors: lu m. J Virol. 2002 Sep;76(17):8875-89. doi: 10.1128/jvi.76.17.8875-8889.2002. J Virol. 2002. PMID: 12163607 Free PMC article.

6

Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry.

Berro R, Sanders RW, Lu M, Klasse PJ, Moore JP. Berro R, et al. Among authors: lu m. PLoS Pathog. 2009 Aug;5(8):e1000548. doi: 10.1371/journal.ppat.1000548. Epub 2009 Aug 14. PLoS Pathog. 2009. PMID: 19680536 Free PMC article.

7

Role of a putative gp41 dimerization domain in human immunodeficiency virus type 1 membrane fusion.

Liu J, Deng Y, Li Q, Dey AK, Moore JP, Lu M. Liu J, et al. Among authors: lu m. J Virol. 2010 Jan;84(1):201-9. doi: 10.1128/JVI.01558-09. J Virol. 2010. PMID: 19846514 Free PMC article.

8

Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.

Deng Y, Zheng Q, Ketas TJ, Moore JP, Lu M. Deng Y, et al. Among authors: lu m. Biochemistry. 2007 Apr 10;46(14):4360-9. doi: 10.1021/bi7001289. Epub 2007 Mar 20. Biochemistry. 2007. PMID: 17371053

9

A heterospecific leucine zipper tetramer.

Deng Y, Liu J, Zheng Q, Li Q, Kallenbach NR, Lu M. Deng Y, et al. Among authors: lu m. Chem Biol. 2008 Sep 22;15(9):908-19. doi: 10.1016/j.chembiol.2008.07.008. Chem Biol. 2008. PMID: 18804028 Free PMC article.

10

Core structure of S2 from the human coronavirus NL63 spike glycoprotein.

Zheng Q, Deng Y, Liu J, van der Hoek L, Berkhout B, Lu M. Zheng Q, et al. Among authors: lu m. Biochemistry. 2006 Dec 26;45(51):15205-15. doi: 10.1021/bi061686w. Epub 2006 Dec 1. Biochemistry. 2006. PMID: 17176042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,159 results

Search Page

Filters